Variation in surgical resection for lung cancer in relation to survival: Population-based study in England 2004–2006
Introduction
Around 40,000 incident cases of lung cancer are diagnosed in the United Kingdom every year, and five-year relative survival is less than 10%.1 Lung cancer survival is known to be lower in England than in other countries with similar health care systems2 and the mortality difference is largest early in the period of follow-up.3 Surgical resection for lung cancer can potentially lead to long-term survival and cure, and it is possible that the low survival in England can in part be ascribed to low resection rates.
Non-small cell lung cancer (NSCLC) comprises over 85% of all lung cancers. In patients with early stage NSCLC, pulmonary resection provides the best form of potentially curative treatment.4 The resection rate in England is reportedly around 10%,5 whereas elsewhere in Europe and the US resection rates of around 20% to 30% are reported.6, 7, 8 However, most internationally reported resection rates are quoted as a proportion of those patients with a confirmed tissue diagnosis of NSCLC whereas previous UK data has used the total lung cancer population (including those diagnosed on clinic-radiological grounds only) as the denominator. It has been shown that resection rates are variable by region.9, 10 Recent data from the English National Lung Cancer Audit showed that 14% of patients with a confirmed NSCLC diagnosis underwent resection, with some hospital trusts having rates of well over 20%.11 [http://www.ic.nhs.uk/webfiles/Services/NCASP/] A recent report from one UK hospital reported a resection rate of 25% for NSCLC.12 The resection rate in NSCLC patients declines above the age of 70 years,13 although there is strong evidence that they respond equally as well as younger patients.14 Higher levels of socio-economic deprivation have been associated with the low use of radical resection for lung cancer.15, 16
The present study was designed to explore the association between lung cancer resection and survival in different parts and subgroups of the English population. The ultimate question is whether it is likely that increasing the use of surgical resection would lead to an increase in lung cancer survival. A priori, we hypothesised that resection and survival would be positively associated in the total lung cancer population (resected patients expectedly living longer than non-resected patients), and negatively associated in the resected patient population (higher surgery rates being associated with surgery being carried out on higher risk patients). The relative magnitudes of these opposing associations could help indicate whether an increase in resection would lead to an increase in the overall lung cancer survival.
Section snippets
Lung cancer patients
We extracted data on 92,952 persons diagnosed with lung cancer (ICD-10 C33-C34) between 2004 and 2006 from the National Cancer Repository Dataset, collated from the regional cancer registries in England and linked with the hospital episode statistics (HES) records.17 Follow-up for death was until 31st December 2006.
We excluded small cell lung cancer (SCLC) (n = 11,428) patients from the analysis of survival in relation to surgical resection because the primary treatment for SCLC is generally
Variation in radical resection
Fig. 1 shows the proportions of lung cancer patients in the 152 PCTs in England who underwent surgical resection. The proportion ranged from 3% to 18% with a median of 9%.
A map of the resection quintiles in PCT areas in England indicated no obvious geographical pattern (data not shown).
Predictors of surgical resection
Initially we analysed the proportions of lung cancer patients who underwent surgical resection in relation to other known characteristics. Resection was highly dependent on age with the proportion of resected
Discussion
Within England, we found variation in the use of surgical resection as a treatment for NSCLC. Higher resection rates were strongly associated with better overall survival and only moderately inversely associated with survival within the resected sub-population. We found these associations both at the level of the 152 PCTs and nine Government Office Regions in England. These associations were independent of age, sex and socio-economic deprivation, but age, sex and socio-economic deprivation
Ethics
Cancer registries in England have approval from the National Information Governance Board to carry out surveillance using the data they collect on all cancer patients under section 251 of the NHS Act 2006. Therefore separate ethical approval was not required for this study.
Role of the funding source
The Thames Cancer Registry in King’s College London receives funding from the Department of Health for England. The views expressed in the article are those of the authors and not necessarily those of the Department of Health.
Conflict of interest statement
None declared.
Acknowledgements
This paper is a contribution from the National Cancer Intelligence Network and is based on the information collected and quality assured by the regional cancer registries in England. (www.ukacr.org; www.ncin.org.uk).
References (33)
Current status of surgical resection for lung cancer
Chest
(1994)- et al.
Variation in survival of patients with lung cancer in Europe, 1985–1989
EUROCARE Working Group. Eur J Cancer.
(1998) - et al.
Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands
Eur J Surg Oncol
(2010) - et al.
Lung cancer in England: information from the National Lung Cancer Audit (LUCADA)
Lung Cancer
(2011) - et al.
Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection
Lung Cancer
(2010) - et al.
Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study
Lung Cancer
(1998) - et al.
Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden)
Lung Cancer
(2009) - et al.
Prognostic models of thirty-day mortality and morbidity after major pulmonary resection
J Thorac Cardiovasc Surg
(1999) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis
Lancet
(2002)- et al.
The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer
Lung Cancer
(2004)
Specialists achieve better outcomes than generalists for lung cancer surgery
Chest
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
Lancet
National comparisons of lung cancer survival in England, Norway and Sweden 2001–2004: differences occur early in follow-up
Thorax
Resection rates and postoperative mortality in 7, 899 patients with lung cancer
Eur Respir J
Cited by (62)
Perioperative cardiovascular pathophysiology in patients undergoing lung resection surgery: a narrative review
2023, British Journal of AnaesthesiaCT screening for lung cancer: Are we ready to implement in Europe?
2019, Lung CancerImproving outcomes in non-small cell lung cancer; population analysis of radical radiotherapy
2019, Radiotherapy and OncologyCitation Excerpt :This suggests that offering radical treatment to patients with poor predicted outcome is unlikely to overcome some of the determinants of the adverse prognosis and may even be detrimental. The relationship between utilisation of radical treatment and outcome in patients with NSCLC has been demonstrated for surgery [3] and for other oncological treatments although the study looked at all lung cancer rather than NSCLC alone [2]. The potential “optimum” utilisation has been suggested but not previously shown.